Skip to main content

Goin Kathleen's Form 4 filing

Palvella Therapeutics, Inc. (PVLA) · filed Nov 21, 2025

Accession no.
0001104659-25-115017
Filed
Nov 21, 2025
Trade date
Nov 19, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $371.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Goin KathleenCIK 0001912570Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 19, 2025Common StockMOption exerciseAcquired+2,154$7.14+$15,379.562,154Direct
Nov 19, 2025Common StockMOption exerciseAcquired+2,148$9.08+$19,503.844,302Direct
Nov 19, 2025Common StockSSaleDisposed−1,500$85.72−$128,5802,802Direct
Nov 19, 2025Common StockSSaleDisposed−2,802$86.51−$242,401.020Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 19, 2025Common StockMOption exerciseDisposed−2,154$0.00$023,705Direct
Nov 19, 2025Common StockMOption exerciseDisposed−2,148$0.00$023,628Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)